Not known Facts About YX-2-107
There was also an apparent dosage-related increase in the percentage of patients with clinically meaningful reductions in medical SLEDAI response with significant enhancements around placebo witnessed with the 600 mg and 1200 mg month-to-month dosages.bacterial infections was uncomplicated in all conditions. These bacterial infections responded